Catalent Inc. (NYSE:CTLT) saw a downside of -3.21% to $50.90 after subtracting -$1.69 on Tuesday. The 5-day average trading volume is 2,485,640 shares of the company’s common stock. It has gained $53.00 in the past week and touched a new high 4 times within the past 5 days. An average of 2,338,960 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,027,610.
CTLT’s 1-month performance is 18.55% or $7.53 on its low of $42.12 reached on 12/27/22. The company’s shares have touched a 52-week low of $40.69 and high of $115.33, with the stock’s rally to the 52-week high happening on 01/24/23. YTD, CTLT has achieved 16.84% or $5.88 and has reached a new high 7 times. However, the current price is down -55.87% from the 52-week high price.
CTLT stock investors last saw insider trading activity on Dec 05.Boerman Manja (Pres. BioModalities Division) most recently sold 780 shares at $51.70 per share on Dec 05. This transaction cost the insider $40,326. SVP, Strategy & Corp. Dev., Grippo Michael J, sold 2,451 shares at a price of $65.83 on Oct 31. Then, on Oct 10, Pres. Pharma Prod Delivery Div Hawkeswood Thomas W sold 930 shares at a price of $77.46 per share. This transaction amounted to $72,038.
CTLT stock has a beta of 1.23. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.96 while the price-to-book (PB) in the most recent quarter is 2.01.
Catalent Inc.’s quick ratio for the period ended September 29 was 2.10, with the current ratio over the same period at 2.90. As well, the company’s long term debt to equity for the quarter ending September 29 was 0.87, while the total debt to equity was 0.89. In terms of profitability, the gross margin trailing 12 months is 32.60%. The firm’s gross profit as reported stood at $1.64 billion against revenue of $4.83 billion.
For the quarterly period ending September 29 this year, Catalent Inc.’s cash and short-term investments amounted to $64.0 million against total debt of $4.22 billion. Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected CTLT to announce $0.56 per share in earnings in its latest quarter, but it posted $0.34, representing a -39.30% surprise. EBITDA for the quarter stood at more than $161.0 million. CTLT stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 5.5 billion, with total debt at $4.22 billion. Shareholders hold equity totaling $179.96 million.
Let’s look briefly at Catalent Inc. (CTLT) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 64.37% to suggest the stock is trending Neutral, with historical volatility in this time period at 42.09%.
The stock’s 5-day moving average is $50.08, reflecting a +6.10% or $2.92 change from its current price. CTLT is currently trading +18.34% above its 20-day SMA, -43.01% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +22.58% and SMA200 by-53.81%.
Stochastic %K and %D was 85.88% and 84.75% and the average true range (ATR) pointed at 2.20. The RSI (14) points at 60.42%, while the 14-day stochastic is at 74.70% with the period’s ATR at 2.16. The stock’s 9-day MACD Oscillator is pointing at 1.39 and 2.20 on the 14-day charts.
In the most recent analyst report for Catalent Inc. (NYSE: CTLT), KeyBanc Capital Markets downgraded it to a Sector weight rating. They previously had an Overweight rating on the stock. Analysts offering their rating for CTLT stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate CTLT as a “sell,”, while 4 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 3 rates the stock as overweight while 8 have offered a “buy” rating.
What is CTLT’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $44.00 and a high of $100.00, with their median price target at $67.00. Looking at these predictions, the average price target given by analysts is for Catalent Inc. (CTLT) stock is $70.64.